A245620 Stock Overview
Provides genetic information analysis services in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Eone Diagnomics Genome Center Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩415.00 |
| 52 Week High | ₩2,075.00 |
| 52 Week Low | ₩349.00 |
| Beta | -2.54 |
| 1 Month Change | 0% |
| 3 Month Change | -5.25% |
| 1 Year Change | -76.14% |
| 3 Year Change | -92.30% |
| 5 Year Change | -84.60% |
| Change since IPO | -92.52% |
Recent News & Updates
Recent updates
There's No Escaping Eone Diagnomics Genome Center Co., Ltd.'s (KOSDAQ:245620) Muted Revenues Despite A 43% Share Price Rise
Feb 29
Is Eone Diagnomics Genome Center (KOSDAQ:245620) Weighed On By Its Debt Load?
Apr 06If You Had Bought Eone Diagnomics Genome Center (KOSDAQ:245620) Shares A Year Ago You'd Have Earned 54% Returns
Feb 24Do Insiders Own Lots Of Shares In Eone Diagnomics Genome Center Co., Ltd. (KOSDAQ:245620)?
Jan 20Eone Diagnomics Genome Center (KOSDAQ:245620) Is Carrying A Fair Bit Of Debt
Dec 16Shareholder Returns
| A245620 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -0.9% |
| 1Y | -76.1% | 32.0% | -9.0% |
Return vs Industry: A245620 underperformed the KR Life Sciences industry which returned 5.3% over the past year.
Return vs Market: A245620 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A245620 volatility | |
|---|---|
| A245620 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 9.8% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A245620's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A245620's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 103 | Min Seob Lee | www.edgc.com |
Eone Diagnomics Genome Center Co., Ltd. provides genetic information analysis services in South Korea. It engages in the genome research and development, genomic testing/screening, IT, and software activities.
Eone Diagnomics Genome Center Co., Ltd. Fundamentals Summary
| A245620 fundamental statistics | |
|---|---|
| Market cap | ₩57.44b |
| Earnings (TTM) | -₩39.88b |
| Revenue (TTM) | ₩73.97b |
0.8x
P/S Ratio-1.4x
P/E RatioIs A245620 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A245620 income statement (TTM) | |
|---|---|
| Revenue | ₩73.97b |
| Cost of Revenue | ₩65.86b |
| Gross Profit | ₩8.11b |
| Other Expenses | ₩47.99b |
| Earnings | -₩39.88b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -288.15 |
| Gross Margin | 10.96% |
| Net Profit Margin | -53.92% |
| Debt/Equity Ratio | 76.8% |
How did A245620 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/03 11:16 |
| End of Day Share Price | 2024/04/05 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eone Diagnomics Genome Center Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tal Mi Lee | SK Securities Co., Ltd. |